Meta-analysis demonstrates DFD-29's superiority in treating moderate-to-severe rosacea, suggesting effective alternatives.
Our meta-analysis showed that DFD-29 at 40 mg daily, is a superior and well-tolerated alternative to modified-release doxycycline for moderate-to-severe rosacea.
No takes yet. Share an insight, caveat, or question.
Ghanem et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: